Stockscreener 앱 받기
0.745
2.17%
-0.0166
전일 마감가:
$0.7616
열려 있는:
$0.75
하루 거래량:
39,093
Relative Volume:
0.59
시가총액:
$12.97M
수익:
$52.58M
순이익/손실:
$-3.28M
주가수익비율:
-3.8661
EPS:
-0.1927
순현금흐름:
$-2.53M
1주 성능:
-12.97%
1개월 성능:
-18.59%
6개월 성능:
-46.40%
1년 성능:
-38.43%
1일 변동 폭
$0.745
$0.75
1주일 범위
$0.7001
$0.9765
52주 변동 폭
$0.7001
$1.6481
Iridex Corp Stock (IRIX) Company Profile
명칭
Iridex Corp
전화
(650) 940-4700
주소
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
0.745 | 13.63M | 52.58M | -3.28M | -2.53M | -0.1927 |
ABT
Abbott Laboratories
|
115.61 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
329.55 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.49 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.84 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.84 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-11-03 | 재개 | ROTH Capital | Buy |
| 2016-12-21 | 개시 | ROTH Capital | Buy |
| 2016-01-26 | 개시 | Singular Research | Buy |
| 2007-01-03 | 개시 | First Albany | Buy |
Iridex Corp 주식(IRIX)의 최신 뉴스
IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 - GuruFocus
IRIX Looks 45.3% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Earnings call transcript: IRIDEX misses Q2 2026 estimates as cash flow turns positive - Investing.com South Africa
IRIDEX Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Is IRIDEX Corp (IRIX) Positioned for Growth After Q2 Earnings Mi - GuruFocus
IRIDEX Q2 Revenue Falls 7% as Retina Weakness Offsets Glaucoma Growth - Minichart
Form 8K IRIDEX Corporation For: 18 August By Investing.com - Investing.com Canada
Full Transcript: Iridex Q2 2026 Earnings Call - Benzinga
IRIDEX Corp reports results for the quarter ended June 30Earnings Summary - TradingView
IRIDEX CORP Q2 2026: Revenue $12.6M, EPS $(0.07) — 10-Q Summary - TradingView
IRIDEX (IRIX) glaucoma sales rise as retina revenue falls - Stock Titan
IRIDEX earnings missed by $0.05, revenue fell short of estimates - Investing.com
Iridex Reports Q2 2026 Revenue $12.6M, Net Loss $1.3M; Cyclo G6 Probe Growth Boosts Glaucoma Sales - TradingView
Iridex falls short on Q2 revenue and earnings expectations - Investing.com
Iridex falls short on Q2 revenue and earnings expectations By Investing.com - Investing.com Australia
IRIDEX ($IRIX) Releases Q2 2026 Earnings - Quiver Quantitative
Iridex Latest Results: FY26 sales guidance affirmed at $51M-$53M, below est - scanx.trade
Iridex Q2 revenue misses estimate as loss widens to $0.07 - scanx.trade
Iridex: Q2 Earnings Snapshot - marketscreener.com
Iridex Reports Second Quarter 2026 Financial Results - GlobeNewswire
Iridex (NASDAQ:IRIX): Why Is Ophthalmic Systems And Procedure Activity in Focus Today? - Kalkine Media
IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 Surges 35% as Company Achieves ... By GuruFocus - Investing.com Canada
IRIX|IRIDEX Corp|Price:0.880|Chg%:+0.024 - TradingKey
IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IRIDEX Corp (IRIX) Stock News Today - TradingKey
Iridex schedules Q2 business update after Aug. 18 close - Stock Titan
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 - Yahoo Finance
IRIX Faces Continued Pressure Near Key Support Levels – IRIDEX Corporation (IRIX) at $0.86Wyckoff Distribution - dars.gov.et
IRIDEX Corp (IRIX) Institutional Confidence - TradingKey
IRIX|IRIDEX Corp|Price:0.889|Chg%:-0.002 - TradingKey
IRIDEX Corp (IRIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRIDEX Corp (IRIX) Cash Flow - TradingKey
IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
IRIX|IRIDEX Corp|Price:0.783|Chg%:-0.147 - TradingKey
IRIDEX Corp (IRIX) Income Statement - TradingKey
IRIDEX Corp (IRIX) Earnings Date & Reports & Earnings News - TradingKey
IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRIDEX Corp (IRIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRIX|IRIDEX Corp|Price:0.930|Chg%:+0.050 - TradingKey
Iridex expands EyeProGPO offering with EndoProbe handpieces - Investing.com
More Than 4,300 EyeProGPO Members Gain Preferred EndoProbe Pricing - Stock Titan
Iridex Expands EyeProGPO Offering to Include EndoProbe Handpieces - Quiver Quantitative
Iridex Board Warns of Legal Risks in Stealth Proxy Campaign by Major Shareholder Novel Inspiration - Minichart
Form 4 IRIDEX Corporation For: 14 July By Investing.com - Investing.com Nigeria
IRIDEX CORP (IRIX) grants CFO 30K RSUs and 170K options - Stock Titan
Form 13D/A IRIDEX CORP For: 13 July By Investing.com - Investing.com Nigeria
Iridex Corp (Nasdaq: IRIX) investor group reports 29.92% ownership stake - Stock Titan
Form 4 IRIDEX Corporation For: 8 July By Investing.com - Investing.com Nigeria
Novel Inspiration gains IRIDEX (IRIX) shares as quarterly note interest - Stock Titan
Iridex Corp (IRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Iridex Corp 주식 (IRIX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
Jun 11 '26 |
Buy |
1.14 |
1,675 |
1,909 |
135,000 |
| Dizon Romeo R | Chief Financial Officer |
Jun 08 '26 |
Buy |
1.12 |
2,400 |
2,688 |
133,325 |
| Dizon Romeo R | Chief Financial Officer |
Jun 05 '26 |
Buy |
1.15 |
2,521 |
2,899 |
130,925 |
| Dizon Romeo R | Chief Financial Officer |
Jun 03 '26 |
Buy |
1.17 |
2,400 |
2,808 |
128,404 |
| Dizon Romeo R | Chief Financial Officer |
May 26 '26 |
Buy |
1.00 |
5,004 |
5,004 |
126,004 |
| Dizon Romeo R | Chief Financial Officer |
Mar 06 '26 |
Buy |
1.26 |
1,110 |
1,399 |
121,000 |
| Dizon Romeo R | Chief Financial Officer |
Feb 17 '26 |
Buy |
1.34 |
2,200 |
2,942 |
119,890 |
| Dizon Romeo R | Chief Financial Officer |
Feb 12 '26 |
Buy |
1.43 |
1,500 |
2,145 |
117,690 |
| Dizon Romeo R | Chief Financial Officer |
Feb 10 '26 |
Buy |
1.46 |
1,000 |
1,460 |
116,190 |
| Dizon Romeo R | Chief Financial Officer |
Feb 03 '26 |
Buy |
1.38 |
2,500 |
3,450 |
115,190 |
0.32%
0.15%
자본화:
|
볼륨(24시간):